IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 303.00
Bid: 300.00
Ask: 306.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.00%)
Open: 303.00
High: 303.00
Low: 303.00
Prev. Close: 303.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM Block Admission Return / Total Voting Rights

20 Feb 2020 18:18

RNS Number : 6728D
MaxCyte, Inc.
20 February 2020
 

SCHEDULE 6

AIM BLOCK ADMISSION RETURN / TOTAL VOTING RIGHTS

 

Please ensure the entries on this return are typed

 

a. Name of company

 

MaxCyte, Inc.

 

b. Name of scheme(s)

 

MaxCyte Long Term Incentive Plan

 

c. Period of return:

 

From 17 November 2018 To 20 February 2020

 

d. Number and class of securities not issued under scheme

 

415,759 ordinary shares of common stock of $0.01 each

 

e. Number of shares issued under scheme during period

 

96,496 ordinary shares of common stock of $0.01 each

 

f. Balance under the scheme not yet issued at the end of the period.

 

319,263 ordinary shares of common stock of $0.01 each

 

g. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission; If additional blocklisting application have been made, under this scheme, since the original listing application please also state the number of shares and the date(s) of admission.

 

1,000,000 ordinary shares of common stock of $0.01 each on 5 May 2017

 

Please confirm your total issued share capital as at the end of this period.

(If you hold any shares in Treasury state the figure separately);

 

57,403,583 (51,444,847 MXCT.L and 5,958,736 MXCS.L)

 

 

Treasury shares (if applicable) ………Nil………….

 

h. Contact name and telephone number for queries;

 

Doug Doerfler, Chief Executive Officer

Ron Holtz, Chief Financial Officer

+1 301 944 1660

 

Date

 

20 February 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCURRWRRNUUUAR
Date   Source Headline
9th Nov 20237:01 amRNSFiling of Form 10-Q
9th Nov 20237:00 amRNSThird Quarter Results
7th Nov 20237:00 amRNSParticipation in Upcoming Investor Conferences
1st Nov 20231:12 pmRNSTotal Voting Rights
5th Oct 20237:00 amRNSPreliminary Q3 Revenue & FY Revenue Guidance
2nd Oct 20234:03 pmRNSTotal Voting Rights
13th Sep 20232:28 pmRNSTR-1: Notification of major holdings
12th Sep 20231:21 pmRNSTR-1: Notification of major holdings
5th Sep 20234:17 pmRNSTR-1: Notification of major holdings
5th Sep 20231:05 pmRNSBaird Global Healthcare Conference Participation
4th Sep 20231:32 pmRNSTR-1: Notification of major holdings
4th Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20239:01 amRNSExercise of options and PDMR dealing
18th Aug 20235:25 pmRNSTR-1
17th Aug 20234:27 pmRNSTR-1: Notification of major holdings
17th Aug 20237:00 amRNSTR-1: Notification of Major Holdings
10th Aug 20237:25 amRNSFiling of Form 10-Q
10th Aug 20237:00 amRNSSecond Quarter and Half-Year Results
8th Aug 20233:15 pmRNSTR-1: Notification of major holdings
7th Aug 20235:01 pmRNSTotal Voting Rights and Block Listing Return
1st Aug 20231:05 pmRNSStrategic Platform License with Prime Medicine
31st Jul 20235:26 pmRNSExercise of options and PDMR dealing
26th Jul 20232:31 pmRNSTR-1: Notification of major holdings
24th Jul 20235:08 pmRNSTR-1: Notification of major holdings
24th Jul 20235:06 pmRNSTR-1: Notification of major holdings
13th Jul 20231:05 pmRNSNotice of Second Quarter 2023 Financial Results
11th Jul 20237:00 amRNSTR-1: Notification of major holdings
10th Jul 20231:05 pmRNSSigning of Strategic Platform License
10th Jul 20237:00 amRNSTR-1: Notification of major holdings
7th Jul 20239:23 amRNSTotal Voting Rights
6th Jul 20234:41 pmRNSTR-1: Notification of major holdings
6th Jul 20231:05 pmRNSSigning of Strategic Platform License
29th Jun 20233:19 pmRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSExercise of options and PDMR dealing
23rd Jun 20233:46 pmRNSGrant of Options
23rd Jun 20237:17 amRNSResult of AGM
23rd Jun 20237:00 amRNSResult of AGM
21st Jun 202310:10 amRNSPublication of Annual Report
16th Jun 202312:32 pmRNSExercise of options and PDMR dealing
2nd Jun 20237:00 amRNSUpcoming Investor Conferences
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20237:22 amRNSFiling of Form 10-Q
11th May 20237:00 amRNSFirst Quarter Financial Results
9th May 20237:00 amRNSExercise of options and PDMR dealing
4th May 20231:05 pmRNSSigning of Strategic Platform License
3rd May 20234:22 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSNotice of First Quarter 2023 Financial Results
30th Mar 202312:46 pmRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.